Global Specialty Pharmaceuticals Market 2023-2027

Report
160 Pages
July 2023
Region: Global
TechNavio
ID: 5868455

The specialty pharmaceuticals market is forecasted to grow by USD 331.12 bn during 2022-2027, accelerating at a CAGR of 12.59% during the forecast period. The report on the specialty pharmaceuticals market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing demand for R and D due to government healthcare expenditure, need for cost-cutting in specialty pharmaceutical discovery and development, and initiatives by government and various non-profit organizations to spread awareness of complex diseases.

The specialty pharmaceuticals market is segmented as below:

By Application

Oncology
Multiple sclerosis
Inflammatory conditions
Infectious diseases
Others

By Distribution Channel

Offline
Online

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the increasing geriatric population as one of the prime reasons driving the specialty pharmaceuticals market growth during the next few years. Also, increase in the R and D investments in specialty pharmaceuticals by manufacturers and rising investments and developments in the biopharmaceutical industry will lead to sizable demand in the market.

The report on the specialty pharmaceuticals market covers the following areas:

Specialty pharmaceuticals market sizing
Specialty pharmaceuticals market forecast
Specialty pharmaceuticals market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading specialty pharmaceuticals market vendors that include AbbVie Inc., Amgen Inc., Biodexa Pharmaceuticals PLC, Bristol Myers Squibb Co., Cigna Corp., CVS Health Corp., Endo International Plc, F. Hoffmann La Roche Ltd., Gilead Sciences Inc., Humana Inc., Hyphens Pharma Pte Ltd., Johnson and Johnson Services Inc., Kroger Co., McKesson Corp., Merck and Co. Inc., Novartis AG, Pfizer Inc., Sanofi, Supernus Pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd., UnitedHealth Group Inc., and Viatris Inc.. Also, the specialty pharmaceuticals market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

4.1 Global specialty pharmaceuticals market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on global specialty pharmaceuticals market 2017 - 2021 ($ billion)
4.2 Application Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Application Segment 2017 - 2021 ($ billion)
4.3 Distribution Channel Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ billion)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)

5 Five Forces Analysis

5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Application

6.1 Market segments
Exhibit 30: Chart on Application - Market share 2022-2027 (%)
Exhibit 31: Data Table on Application - Market share 2022-2027 (%)
6.2 Comparison by Application
Exhibit 32: Chart on Comparison by Application
Exhibit 33: Data Table on Comparison by Application
6.3 Oncology - Market size and forecast 2022-2027
Exhibit 34: Chart on Oncology - Market size and forecast 2022-2027 ($ billion)
Exhibit 35: Data Table on Oncology - Market size and forecast 2022-2027 ($ billion)
Exhibit 36: Chart on Oncology - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Oncology - Year-over-year growth 2022-2027 (%)
6.4 Multiple sclerosis - Market size and forecast 2022-2027
Exhibit 38: Chart on Multiple sclerosis - Market size and forecast 2022-2027 ($ billion)
Exhibit 39: Data Table on Multiple sclerosis - Market size and forecast 2022-2027 ($ billion)
Exhibit 40: Chart on Multiple sclerosis - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Multiple sclerosis - Year-over-year growth 2022-2027 (%)
6.5 Inflammatory conditions - Market size and forecast 2022-2027
Exhibit 42: Chart on Inflammatory conditions - Market size and forecast 2022-2027 ($ billion)
Exhibit 43: Data Table on Inflammatory conditions - Market size and forecast 2022-2027 ($ billion)
Exhibit 44: Chart on Inflammatory conditions - Year-over-year growth 2022-2027 (%)
Exhibit 45: Data Table on Inflammatory conditions - Year-over-year growth 2022-2027 (%)
6.6 Infectious diseases - Market size and forecast 2022-2027
Exhibit 46: Chart on Infectious diseases - Market size and forecast 2022-2027 ($ billion)
Exhibit 47: Data Table on Infectious diseases - Market size and forecast 2022-2027 ($ billion)
Exhibit 48: Chart on Infectious diseases - Year-over-year growth 2022-2027 (%)
Exhibit 49: Data Table on Infectious diseases - Year-over-year growth 2022-2027 (%)
6.7 Others - Market size and forecast 2022-2027
Exhibit 50: Chart on Others - Market size and forecast 2022-2027 ($ billion)
Exhibit 51: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
Exhibit 52: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 53: Data Table on Others - Year-over-year growth 2022-2027 (%)
6.8 Market opportunity by Application
Exhibit 54: Market opportunity by Application ($ billion)
Exhibit 55: Data Table on Market opportunity by Application ($ billion)

7 Market Segmentation by Distribution Channel

7.1 Market segments
Exhibit 56: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibit 57: Data Table on Distribution Channel - Market share 2022-2027 (%)
7.2 Comparison by Distribution Channel
Exhibit 58: Chart on Comparison by Distribution Channel
Exhibit 59: Data Table on Comparison by Distribution Channel
7.3 Offline - Market size and forecast 2022-2027
Exhibit 60: Chart on Offline - Market size and forecast 2022-2027 ($ billion)
Exhibit 61: Data Table on Offline - Market size and forecast 2022-2027 ($ billion)
Exhibit 62: Chart on Offline - Year-over-year growth 2022-2027 (%)
Exhibit 63: Data Table on Offline - Year-over-year growth 2022-2027 (%)
7.4 Online - Market size and forecast 2022-2027
Exhibit 64: Chart on Online - Market size and forecast 2022-2027 ($ billion)
Exhibit 65: Data Table on Online - Market size and forecast 2022-2027 ($ billion)
Exhibit 66: Chart on Online - Year-over-year growth 2022-2027 (%)
Exhibit 67: Data Table on Online - Year-over-year growth 2022-2027 (%)
7.5 Market opportunity by Distribution Channel
Exhibit 68: Market opportunity by Distribution Channel ($ billion)
Exhibit 69: Data Table on Market opportunity by Distribution Channel ($ billion)

8 Customer Landscape

8.1 Customer landscape overview
Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
Exhibit 71: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 72: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 73: Chart on Geographic comparison
Exhibit 74: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 75: Chart on North America - Market size and forecast 2022-2027 ($ billion)
Exhibit 76: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
Exhibit 77: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 78: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 79: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibit 80: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibit 81: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 83: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibit 84: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibit 85: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 91: Chart on US - Market size and forecast 2022-2027 ($ billion)
Exhibit 92: Data Table on US - Market size and forecast 2022-2027 ($ billion)
Exhibit 93: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 China - Market size and forecast 2022-2027
Exhibit 95: Chart on China - Market size and forecast 2022-2027 ($ billion)
Exhibit 96: Data Table on China - Market size and forecast 2022-2027 ($ billion)
Exhibit 97: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on China - Year-over-year growth 2022-2027 (%)
9.9 Germany - Market size and forecast 2022-2027
Exhibit 99: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibit 100: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibit 101: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 102: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.10 Japan - Market size and forecast 2022-2027
Exhibit 103: Chart on Japan - Market size and forecast 2022-2027 ($ billion)
Exhibit 104: Data Table on Japan - Market size and forecast 2022-2027 ($ billion)
Exhibit 105: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibit 106: Data Table on Japan - Year-over-year growth 2022-2027 (%)
9.11 UK - Market size and forecast 2022-2027
Exhibit 107: Chart on UK - Market size and forecast 2022-2027 ($ billion)
Exhibit 108: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
Exhibit 109: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 110: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 111: Market opportunity By Geographical Landscape ($ billion)
Exhibit 112: Data Tables on Market opportunity By Geographical Landscape ($ billion)

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 113: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
Exhibit 114: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 115: Overview on factors of disruption
11.4 Industry risks
Exhibit 116: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
Exhibit 117: Vendors covered
12.2 Market positioning of vendors
Exhibit 118: Matrix on vendor position and classification
12.3 AbbVie Inc.
Exhibit 119: AbbVie Inc. - Overview
Exhibit 120: AbbVie Inc. - Product/Service
Exhibit 121: AbbVie Inc. - Key news
Exhibit 122: AbbVie Inc. - Key offerings
12.4 Amgen Inc.
Exhibit 123: Amgen Inc. - Overview
Exhibit 124: Amgen Inc. - Product/Service
Exhibit 125: Amgen Inc. - Key offerings
12.5 Biodexa Pharmaceuticals PLC
Exhibit 126: Biodexa Pharmaceuticals PLC - Overview
Exhibit 127: Biodexa Pharmaceuticals PLC - Product/Service
Exhibit 128: Biodexa Pharmaceuticals PLC - Key offerings
12.6 Bristol Myers Squibb Co.
Exhibit 129: Bristol Myers Squibb Co. - Overview
Exhibit 130: Bristol Myers Squibb Co. - Product/Service
Exhibit 131: Bristol Myers Squibb Co. - Key news
Exhibit 132: Bristol Myers Squibb Co. - Key offerings
12.7 Cigna Corp.
Exhibit 133: Cigna Corp. - Overview
Exhibit 134: Cigna Corp. - Product/Service
Exhibit 135: Cigna Corp. - Key offerings
12.8 F. Hoffmann La Roche Ltd.
Exhibit 136: F. Hoffmann La Roche Ltd. - Overview
Exhibit 137: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 138: F. Hoffmann La Roche Ltd. - Key news
Exhibit 139: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 140: F. Hoffmann La Roche Ltd. - Segment focus
12.9 Gilead Sciences Inc.
Exhibit 141: Gilead Sciences Inc. - Overview
Exhibit 142: Gilead Sciences Inc. - Product/Service
Exhibit 143: Gilead Sciences Inc. - Key news
Exhibit 144: Gilead Sciences Inc. - Key offerings
12.10 Johnson and Johnson Services Inc.
Exhibit 145: Johnson and Johnson Services Inc. - Overview
Exhibit 146: Johnson and Johnson Services Inc. - Business segments
Exhibit 147: Johnson and Johnson Services Inc. - Key news
Exhibit 148: Johnson and Johnson Services Inc. - Key offerings
Exhibit 149: Johnson and Johnson Services Inc. - Segment focus
12.11 McKesson Corp.
Exhibit 150: McKesson Corp. - Overview
Exhibit 151: McKesson Corp. - Business segments
Exhibit 152: McKesson Corp. - Key offerings
Exhibit 153: McKesson Corp. - Segment focus
12.12 Merck and Co. Inc.
Exhibit 154: Merck and Co. Inc. - Overview
Exhibit 155: Merck and Co. Inc. - Business segments
Exhibit 156: Merck and Co. Inc. - Key news
Exhibit 157: Merck and Co. Inc. - Key offerings
Exhibit 158: Merck and Co. Inc. - Segment focus
12.13 Novartis AG
Exhibit 159: Novartis AG - Overview
Exhibit 160: Novartis AG - Business segments
Exhibit 161: Novartis AG - Key offerings
Exhibit 162: Novartis AG - Segment focus
12.14 Pfizer Inc.
Exhibit 163: Pfizer Inc. - Overview
Exhibit 164: Pfizer Inc. - Product/Service
Exhibit 165: Pfizer Inc. - Key news
Exhibit 166: Pfizer Inc. - Key offerings
12.15 Sanofi
Exhibit 167: Sanofi - Overview
Exhibit 168: Sanofi - Business segments
Exhibit 169: Sanofi - Key news
Exhibit 170: Sanofi - Key offerings
Exhibit 171: Sanofi - Segment focus
12.16 Teva Pharmaceutical Industries Ltd.
Exhibit 172: Teva Pharmaceutical Industries Ltd. - Overview
Exhibit 173: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibit 174: Teva Pharmaceutical Industries Ltd. - Key news
Exhibit 175: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibit 176: Teva Pharmaceutical Industries Ltd. - Segment focus
12.17 Viatris Inc.
Exhibit 177: Viatris Inc. - Overview
Exhibit 178: Viatris Inc. - Business segments
Exhibit 179: Viatris Inc. - Key news
Exhibit 180: Viatris Inc. - Key offerings
Exhibit 181: Viatris Inc. - Segment focus

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 182: Inclusions checklist
Exhibit 183: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 184: Currency conversion rates for US$
13.4 Research methodology
Exhibit 185: Research methodology
Exhibit 186: Validation techniques employed for market sizing
Exhibit 187: Information sources
13.5 List of abbreviations
Exhibit 188: List of abbreviations

List of Exhibits

Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Application
Exhibits 6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
Exhibits 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
Exhibits 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 18: Historic Market Size - Data Table on global specialty pharmaceuticals market 2017 - 2021 ($ billion)
Exhibits 19: Historic Market Size - Application Segment 2017 - 2021 ($ billion)
Exhibits 20: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ billion)
Exhibits 21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
Exhibits 22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)
Exhibits 23: Five forces analysis - Comparison between 2022 and 2027
Exhibits 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits 26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits 27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits 28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits 29: Chart on Market condition - Five forces 2022 and 2027
Exhibits 30: Chart on Application - Market share 2022-2027 (%)
Exhibits 31: Data Table on Application - Market share 2022-2027 (%)
Exhibits 32: Chart on Comparison by Application
Exhibits 33: Data Table on Comparison by Application
Exhibits 34: Chart on Oncology - Market size and forecast 2022-2027 ($ billion)
Exhibits 35: Data Table on Oncology - Market size and forecast 2022-2027 ($ billion)
Exhibits 36: Chart on Oncology - Year-over-year growth 2022-2027 (%)
Exhibits 37: Data Table on Oncology - Year-over-year growth 2022-2027 (%)
Exhibits 38: Chart on Multiple sclerosis - Market size and forecast 2022-2027 ($ billion)
Exhibits 39: Data Table on Multiple sclerosis - Market size and forecast 2022-2027 ($ billion)
Exhibits 40: Chart on Multiple sclerosis - Year-over-year growth 2022-2027 (%)
Exhibits 41: Data Table on Multiple sclerosis - Year-over-year growth 2022-2027 (%)
Exhibits 42: Chart on Inflammatory conditions - Market size and forecast 2022-2027 ($ billion)
Exhibits 43: Data Table on Inflammatory conditions - Market size and forecast 2022-2027 ($ billion)
Exhibits 44: Chart on Inflammatory conditions - Year-over-year growth 2022-2027 (%)
Exhibits 45: Data Table on Inflammatory conditions - Year-over-year growth 2022-2027 (%)
Exhibits 46: Chart on Infectious diseases - Market size and forecast 2022-2027 ($ billion)
Exhibits 47: Data Table on Infectious diseases - Market size and forecast 2022-2027 ($ billion)
Exhibits 48: Chart on Infectious diseases - Year-over-year growth 2022-2027 (%)
Exhibits 49: Data Table on Infectious diseases - Year-over-year growth 2022-2027 (%)
Exhibits 50: Chart on Others - Market size and forecast 2022-2027 ($ billion)
Exhibits 51: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
Exhibits 52: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits 53: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits 54: Market opportunity by Application ($ billion)
Exhibits 55: Data Table on Market opportunity by Application ($ billion)
Exhibits 56: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibits 57: Data Table on Distribution Channel - Market share 2022-2027 (%)
Exhibits 58: Chart on Comparison by Distribution Channel
Exhibits 59: Data Table on Comparison by Distribution Channel
Exhibits 60: Chart on Offline - Market size and forecast 2022-2027 ($ billion)
Exhibits 61: Data Table on Offline - Market size and forecast 2022-2027 ($ billion)
Exhibits 62: Chart on Offline - Year-over-year growth 2022-2027 (%)
Exhibits 63: Data Table on Offline - Year-over-year growth 2022-2027 (%)
Exhibits 64: Chart on Online - Market size and forecast 2022-2027 ($ billion)
Exhibits 65: Data Table on Online - Market size and forecast 2022-2027 ($ billion)
Exhibits 66: Chart on Online - Year-over-year growth 2022-2027 (%)
Exhibits 67: Data Table on Online - Year-over-year growth 2022-2027 (%)
Exhibits 68: Market opportunity by Distribution Channel ($ billion)
Exhibits 69: Data Table on Market opportunity by Distribution Channel ($ billion)
Exhibits 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 71: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits 72: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits 73: Chart on Geographic comparison
Exhibits 74: Data Table on Geographic comparison
Exhibits 75: Chart on North America - Market size and forecast 2022-2027 ($ billion)
Exhibits 76: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
Exhibits 77: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits 78: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits 79: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibits 80: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibits 81: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 82: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 83: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibits 84: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibits 85: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 86: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 87: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibits 88: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibits 89: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 90: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 91: Chart on US - Market size and forecast 2022-2027 ($ billion)
Exhibits 92: Data Table on US - Market size and forecast 2022-2027 ($ billion)
Exhibits 93: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits 94: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits 95: Chart on China - Market size and forecast 2022-2027 ($ billion)
Exhibits 96: Data Table on China - Market size and forecast 2022-2027 ($ billion)
Exhibits 97: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits 98: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits 99: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibits 100: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibits 101: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 102: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 103: Chart on Japan - Market size and forecast 2022-2027 ($ billion)
Exhibits 104: Data Table on Japan - Market size and forecast 2022-2027 ($ billion)
Exhibits 105: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibits 106: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibits 107: Chart on UK - Market size and forecast 2022-2027 ($ billion)
Exhibits 108: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
Exhibits 109: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits 110: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits 111: Market opportunity By Geographical Landscape ($ billion)
Exhibits 112: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits 113: Impact of drivers and challenges in 2022 and 2027
Exhibits 114: Overview on Criticality of inputs and Factors of differentiation
Exhibits 115: Overview on factors of disruption
Exhibits 116: Impact of key risks on business
Exhibits 117: Vendors covered
Exhibits 118: Matrix on vendor position and classification
Exhibits 119: AbbVie Inc. - Overview
Exhibits 120: AbbVie Inc. - Product/Service
Exhibits 121: AbbVie Inc. - Key news
Exhibits 122: AbbVie Inc. - Key offerings
Exhibits 123: Amgen Inc. - Overview
Exhibits 124: Amgen Inc. - Product/Service
Exhibits 125: Amgen Inc. - Key offerings
Exhibits 126: Biodexa Pharmaceuticals PLC - Overview
Exhibits 127: Biodexa Pharmaceuticals PLC - Product/Service
Exhibits 128: Biodexa Pharmaceuticals PLC - Key offerings
Exhibits 129: Bristol Myers Squibb Co. - Overview
Exhibits 130: Bristol Myers Squibb Co. - Product/Service
Exhibits 131: Bristol Myers Squibb Co. - Key news
Exhibits 132: Bristol Myers Squibb Co. - Key offerings
Exhibits 133: Cigna Corp. - Overview
Exhibits 134: Cigna Corp. - Product/Service
Exhibits 135: Cigna Corp. - Key offerings
Exhibits 136: F. Hoffmann La Roche Ltd. - Overview
Exhibits 137: F. Hoffmann La Roche Ltd. - Business segments
Exhibits 138: F. Hoffmann La Roche Ltd. - Key news
Exhibits 139: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits 140: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits 141: Gilead Sciences Inc. - Overview
Exhibits 142: Gilead Sciences Inc. - Product/Service
Exhibits 143: Gilead Sciences Inc. - Key news
Exhibits 144: Gilead Sciences Inc. - Key offerings
Exhibits 145: Johnson and Johnson Services Inc. - Overview
Exhibits 146: Johnson and Johnson Services Inc. - Business segments
Exhibits 147: Johnson and Johnson Services Inc. - Key news
Exhibits 148: Johnson and Johnson Services Inc. - Key offerings
Exhibits 149: Johnson and Johnson Services Inc. - Segment focus
Exhibits 150: McKesson Corp. - Overview
Exhibits 151: McKesson Corp. - Business segments
Exhibits 152: McKesson Corp. - Key offerings
Exhibits 153: McKesson Corp. - Segment focus
Exhibits 154: Merck and Co. Inc. - Overview
Exhibits 155: Merck and Co. Inc. - Business segments
Exhibits 156: Merck and Co. Inc. - Key news
Exhibits 157: Merck and Co. Inc. - Key offerings
Exhibits 158: Merck and Co. Inc. - Segment focus
Exhibits 159: Novartis AG - Overview
Exhibits 160: Novartis AG - Business segments
Exhibits 161: Novartis AG - Key offerings
Exhibits 162: Novartis AG - Segment focus
Exhibits 163: Pfizer Inc. - Overview
Exhibits 164: Pfizer Inc. - Product/Service
Exhibits 165: Pfizer Inc. - Key news
Exhibits 166: Pfizer Inc. - Key offerings
Exhibits 167: Sanofi - Overview
Exhibits 168: Sanofi - Business segments
Exhibits 169: Sanofi - Key news
Exhibits 170: Sanofi - Key offerings
Exhibits 171: Sanofi - Segment focus
Exhibits 172: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits 173: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits 174: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits 175: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits 176: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits 177: Viatris Inc. - Overview
Exhibits 178: Viatris Inc. - Business segments
Exhibits 179: Viatris Inc. - Key news
Exhibits 180: Viatris Inc. - Key offerings
Exhibits 181: Viatris Inc. - Segment focus
Exhibits 182: Inclusions checklist
Exhibits 183: Exclusions checklist
Exhibits 184: Currency conversion rates for US$
Exhibits 185: Research methodology
Exhibits 186: Validation techniques employed for market sizing
Exhibits 187: Information sources
Exhibits 188: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global specialty pharmaceuticals market: AbbVie Inc., Amgen Inc., Biodexa Pharmaceuticals PLC, Bristol Myers Squibb Co., Cigna Corp., CVS Health Corp., Endo International Plc, F. Hoffmann La Roche Ltd., Gilead Sciences Inc., Humana Inc., Hyphens Pharma Pte Ltd., Johnson and Johnson Services Inc., Kroger Co., McKesson Corp., Merck and Co. Inc., Novartis AG, Pfizer Inc., Sanofi, Supernus Pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd., UnitedHealth Group Inc., and Viatris Inc..

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is increasing geriatric population.'

According to the report, one of the major drivers for this market is the increasing demand for R and D due to government healthcare expenditure.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

AbbVie Inc.
Amgen Inc.
Biodexa Pharmaceuticals PLC
Bristol Myers Squibb Co.
Cigna Corp.
CVS Health Corp.
Endo International Plc
F. Hoffmann La Roche Ltd.
Gilead Sciences Inc.
Humana Inc.
Hyphens Pharma Pte Ltd.
Johnson and Johnson Services Inc.
Kroger Co.
McKesson Corp.
Merck and Co. Inc.
Novartis AG
Pfizer Inc.
Sanofi
Supernus Pharmaceuticals Inc.
Teva Pharmaceutical Industries Ltd.
UnitedHealth Group Inc.
Viatris Inc.

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€2415EUR$2,500USD£2,066GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€3863EUR$4,000USD£3,306GBP

The specialty pharmaceuticals market is segmented as below:

By Application

By Distribution Channel

By Geographical Landscape

The report on the specialty pharmaceuticals market covers the following areas:

Table of Contents

Executive Summary

Companies Mentioned (Partial List)

Related Topics

Related Reports

Global Specialty Pharmaceuticals Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis

Global Specialty Pharmaceuticals Market by Type (CNS, Infectious Diseases, Oncology), Product (Oral Pharmaceuticals, Parenteral Pharmaceuticals, Transdermal Pharmaceuticals), Distribution Channel - Forecast 2024-2030

Specialty Pharmaceuticals Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

Specialty Pharmaceutical Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

Global Antithrombotic Drugs Market 2023-2027